Table 2 Comparison of endpoints at six weeks expressed as changes from baseline.
Treatment | Placebo | P value | |
|---|---|---|---|
Total Cholesterol (mmol/L) | -0.3 ± 0.1 *** | -0.1 ± 0.08 | 0.184 |
LDL cholesterol (mmol/L)** | -0.3 ± 0.1 *** | -0.04 ± 0.08 | 0.026 |
HDL cholesterol (mmol/L) | -0.02 ± 0.02 | -0.009 ± 0.02 | 0.842 |
Triglyceride (mmol/L)* | 0.09 ± 0.1 | -0.2 ± 0.1*** | 0.030 |
Cholesterol/HDL ratio | -0.2 ± 0.1 | -0.1 ± 0.1 | 0.947 |
C-Reactive protein (mg/dL) | -0.03 ± 0.06 | 0.01 ± 0.04 | 0.546 |
Homocysteine (μM/L) | 0.4 ± 0.4 | 0.2 ± 0.2 | 0.528 |
Insulin (pmol/L) | 6.9 ± 4.9 | 4.2 ± 10.4 | 0.804 |
Glucose (mmol/L) | 0.2 ± 0.09 | 0.03 ± 0.09 | 0.259 |
Weight (kg) | -0.7 ± 0.3 | 1.4 ± 1.3 | 0.117 |
Blood pressure (systolic/diastolic, mmHg, value at end point) | 119/69 ± 1.9/1.3 | 119/69 ± 2.0/1.7 | 0.832/0.856 |
Total Energy Intake per day (kJ) | -519 ± 330 | -343 ± 360 | 0.724 |
Carbohydrate intake (% of total) | 0.4 ± 2.0 | 1.8 ± 1.3 | 0.535 |
Protein Intake (% of total) | 0.9 ± 0.6 | -0.9 ± 1.1 | 0.041 |
Fat Intake (% of total) | -0.7 ± 1.8 | -1.2 ± 1.1 | 0.784 |
Dietary Fiber Intake (grams) | -0.3 ± 1.1 | -1.4 ± 1.6 | 0.454 |